Page 121 - Simplicity is Key in CRT
P. 121
References
1. Abraham WT, et al. Cardiac resynchronization in chronic heart failure. The New England journal of medicine. 2002;346:1845-53.
2. Cleland JG, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. The New England journal of medicine. 2005;352:1539-49.
3. Daubert JC, et al. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace. 2012;14:1236-86.
4. Epstein AE, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350-408.
5. Gold MR, et al. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study. Circulation. 2012;126:822-9.
6. Zareba W, et al. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the MultiCentre Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011;123:1061-72.
7. Epstein AE, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device- based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61:e6-75.
8. Varma N, et al. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB. Heart rhythm : the official journal of the Heart Rhythm Society. 2014;11:1139-47.
9. De Pooter J, et al. Different Methods to Measure QRS Duration in CRT Patients: Impact on the Predictive Value of QRS Duration Parameters. Ann Noninvasive Electrocardiol. 2016;21:305-15.
10. van Deursen CJ, et al. The value of the 12-lead ECG for evaluation and optimization of cardiac resynchronization therapy in daily clinical practice. Journal of electrocardiology. 2014;47:202-11.
11. Tereshchenko LG, et al. Novel measure of electrical dyssynchrony predicts response in cardiac resynchronization therapy: Results from the SMART-AV Trial. Heart Rhythm. 2015;12:2402-10.
12. van Deursen CJ, et al. Vectorcardiographic QRS area as a novel predictor of response to cardiac resynchronization therapy. J Electrocardiol. 2015;48:45-52.
13. Mafi Rad M, et al. Vectorcardiographic QRS area identifies delayed left ventricular lateral wall activation determined by electroanatomic mapping in candidates for cardiac resynchronization therapy. Heart Rhythm. 2016;13:217-25.
14. Maass AH, et al. Refining success of cardiac resynchronization therapy using a simple score predicting the amount of reverse ventricular remodelling: results from the Markers and Response to CRT (MARC) study. Europace. 2017. Feb 1;20(2):e1-e10
15. Linde C, et al. Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to aetiology: results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study. Journal of the American College of Cardiology. 2010;56:1826-31.
16. Engels EB, et al. T-wave area predicts response to cardiac resynchronization therapy in patients with left bundle branch block. J Cardiovasc Electrophysiol. 2015;26:176-83.
17. Engels EB, et al. The synthesized vectorcardiogram resembles the measured vectorcardiogram in patients with dyssynchronous heart failure. J Electrocardiol. 2015;48:586-92.
18. Kors JA, et al. Reconstruction of the Frank vectorcardiogram from standard electrocardiographic leads: diagnostic comparison of different methods. Eur Heart J. 1990;11:1083-92.
19. Nguyen UC, et al. Relationship between vectorcardiographic QRSarea, myocardial scar quantification, and response to cardiac resynchronization therapy. J Electrocardiol. 2018. May - Jun;51(3):457-463
20. Birnie DH, et al. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail. 2013;6:1190-8.
21. Selzman K and Shein M. QRS morphology rather than QRS duration for predicting CRT response. Arch Intern Med.
2011;171:1859-60; author reply 1860-1.
22. Zusterzeel R, et al. Sex-specific mortality risk by QRS morphology and duration in patients receiving CRT: results from the
NCDR. J Am Coll Cardiol. 2014;64:887-94.
121
